COVID-19 antibodies persist, reduce reinfection risk for up to six months: Study – ANI News

Michigan [US], September 15 (ANI): A new study has found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months.

ANI | Updated: Sep 15, 2021 10:21 IST
Michigan

See this full article at ANI News

Other news: